Skip to main content
. 2020 Jun 18;12(6):1609. doi: 10.3390/cancers12061609

Figure 8.

Figure 8

Nanotechnology for NSCLC. Summary of the mentioned examples describing different encapsulation systems. (a) Poly(ethylene glycol)–b-poly(lactic acid) (PLA–b-PEG) nanoparticles encapsulating Paclitaxel (Genexol-PM®) (NCT01023347, NCT01770795). (b) Solid–lipid nanoparticle formation for Paclitaxel encapsulation [99]. (c) Supernanoparticles for photothermal therapy in combination with Immune Checkpoint Inhibitors (ICIs) immunotherapy [119]. (d) Assembly of high-density-lipoprotein nanodiscs for doxorubicin delivery [115]. (e) Encapsulation of RNA in polyplexes, formed by cationic polymers [144,145,146].